CH398884A - Verfahren zur Herstellung von Rifamycin - Google Patents

Verfahren zur Herstellung von Rifamycin

Info

Publication number
CH398884A
CH398884A CH740360A CH740360A CH398884A CH 398884 A CH398884 A CH 398884A CH 740360 A CH740360 A CH 740360A CH 740360 A CH740360 A CH 740360A CH 398884 A CH398884 A CH 398884A
Authority
CH
Switzerland
Prior art keywords
rifamycin
fermentation
medium
production
hours
Prior art date
Application number
CH740360A
Other languages
German (de)
English (en)
Inventor
Margalith Pinhas
Sensi Piero
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of CH398884A publication Critical patent/CH398884A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C12P17/189Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms containing the rifamycin nucleus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH740360A 1959-07-20 1960-06-30 Verfahren zur Herstellung von Rifamycin CH398884A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24882/59A GB921045A (en) 1959-07-20 1959-07-20 Production of rifamycin b

Publications (1)

Publication Number Publication Date
CH398884A true CH398884A (de) 1966-03-15

Family

ID=10218742

Family Applications (1)

Application Number Title Priority Date Filing Date
CH740360A CH398884A (de) 1959-07-20 1960-06-30 Verfahren zur Herstellung von Rifamycin

Country Status (5)

Country Link
BE (1) BE592849A (es)
CH (1) CH398884A (es)
ES (1) ES259611A1 (es)
GB (1) GB921045A (es)
SE (1) SE213190C1 (es)

Also Published As

Publication number Publication date
ES259611A1 (es) 1960-11-01
SE213190C1 (es) 1967-05-30
BE592849A (fr) 1960-10-31
GB921045A (en) 1963-03-13

Similar Documents

Publication Publication Date Title
EP0144017A1 (de) Verfahren zur biotechnologischen Herstellung von Poly-D(-)-3-hydroxybuttersäure
DE3486277T2 (de) Verfahren zur Herstellung von Riboflavin.
DE2301079A1 (de) Verfahren zur herstellung von citronensaeure und bzw. oder isocitronensaeure auf mikrobiologischem wege
DE2120930B2 (de) Pepsin-Inhibitor und Verfahren zu dessen Herstellung
CH398884A (de) Verfahren zur Herstellung von Rifamycin
DE2108404C3 (de) Verfahren zur Erzeugung von L-Arginin durch Mikroorganismen
DE3123001C2 (es)
DE2358496C2 (de) Herstellung von L-Serin
DE1018588B (de) Verfahren zur Herstellung von Griseofulvin auf biologischem Wege
AT218673B (de) Verfahren zur Herstellung von Rifomycin B
DE2517941A1 (de) Verfahren zur herstellung von d-weinsaeure
DE2344006B2 (de) Verfahren zur biotechnischen behandlung von epsilon-caprolactam enthaltenden abwaessern
DE1113288B (de) Verfahren zur Herstellung von Rifomycin B auf fermentativem Wege
DE2202701C3 (de) Verfahren zur biotechnischen Herstellung von Zitronensäure
DE2142916A1 (de) Verfahren zur Herstellung von Enzymen mit Hilfe von Kohlenwasserstoffen
DE2254505A1 (de) Verfahren zur herstellung von cephalosporin c
DE3044969C2 (de) Herstellung von Coproporphyrin III
DE1792819C2 (de) Tenebrimycin-Antibiotikum VI und ein Verfahren zu dessen Herstellung
AT347384B (de) Verfahren zur herstellung von hefeproteinen aus sulfitablauge und sulfitablaugeschlempe
DE939397C (de) Verfahren zur Herstellung und Gewinnung eines Produktes mit antiviraler Aktivitaet
US2988490A (en) Production of rifomycin
DE1417575C (de) Verfahren zum Herstellen saure resistenter Protease
AT379613B (de) Verfahren zur biotechnologischen herstellung von poly-d-(-)-3-hydroxybuttersaeure
DE1442258C (de) Verfahren zur Herstellung von L-Glutaminsaure
AT220293B (de) Verfahren zur Herstellung eines neuen Antibiotikums